 Altimmune, Inc. NASDAQ:ALT Q2 2022 Results Conference Call August 11, 2022 8:30 AM ET Company Participants Richard Eisenstadt - Chief Financial Officer Vipin Garg - President and Chief Executive Officer Scot Roberts - Chief Scientific Officer Scott Harris - Chief Medical Officer Conference Call Participants Seamus Fernandez - Guggenheim Yasmeen Rahimi - Piper Sandler Roger Song - Jefferies Mayank Mamtani - B. Riley Jon Welandon - JMP Securities Patrick Trucchio - H.C. 